United States · FDA National Drug Code directory
Rivastigmine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-015_862f0b42-695e-4170-983d-cfb848967cf3
- Product NDC
- 71209-015
- Form
- CAPSULE
- Composition / generic term
- Rivastigmine Tartrate
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140211
- Source listing expiry
- 20261231
Source-listed ingredients
- RIVASTIGMINE TARTRATE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (71209-015-03) · 71209-015-03
- 500 CAPSULE in 1 BOTTLE (71209-015-10) · 71209-015-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →